359 filings
Page 4 of 18
4
vz1kzi vv3
3 Jul 23
AVENUE THERAPEUTICS / Alexandra MacLean ownership change
1:05pm
424B3
7mnm5pk93
28 Jun 23
Prospectus supplement
4:56pm
EFFECT
wbjbic
28 Jun 23
Notice of effectiveness
12:15am
8-K
fceeo 5g73s5d
26 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
CORRESP
l5rnje904fp0fysllzzr
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
tryfqoq7 ccamho
22 Jun 23
Letter from SEC
12:00am
8-K
mj1047n
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
6lan2h625o55qwo
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
424B3
784eb2r7
4 May 23
Prospectus supplement
4:30pm
EFFECT
vvf86tgm pm6nolkfe
4 May 23
Notice of effectiveness
12:15am
CORRESP
kjryge3s8 22vfpn0
1 May 23
Correspondence with SEC
12:00am
DEFA14A
zuh9 vay3dje4tq
28 Apr 23
Additional proxy soliciting materials
4:15pm
8-K
jkuhz98dik8uz9
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm
UPLOAD
cwfnyqr
17 Apr 23
Letter from SEC
12:00am
4
kpabg5fi
4 Apr 23
Change in insider ownership
4:08pm